Relationships of alpha-SMA-positive fibroblasts and SDF-1-positive tumor cells with neoangiogenesis in nasopharyngeal carcinoma

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Wang, Shumin ^a,b   Ma, Ning ^c   Kawanishi, Shosuke ^c   Hiraku, Yusuke ^a   Oikawa, Shinji ^a   Xie, Ying ^b   Zhang, Zhe ^b   Huang, Guangwu ^b   Murata, Mariko ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^c SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD133 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2; ACTA2 PROTEIN, HUMAN; ACTIN; CXCL12 PROTEIN, HUMAN; TUMOR PROTEIN;

ADULT; ANGIOGENESIS; ARTICLE; CANCER ASSOCIATED FIBROBLAST; CANCER CELL; CANCER TISSUE; CAPILLARY DENSITY; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; FEMALE; FIBROBLAST; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; RHINOPHARYNGITIS; CHINA; CLINICAL TRIAL; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; NASOPHARYNGEAL NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY;

ACTINS; ADULT; CHEMOKINE CXCL12; CHINA; FEMALE; FIBROBLASTS; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84901289718     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/507353     Document Type: Article

References (45)

1. Kalluri R., Basement membranes: structure, assembly and role in tumour angiogenesis. Nature Reviews Cancer 2003 3 6 422 433 2-s2.0-0037805549 10.1038/nrc1094 (Pubitemid 37328846)
2. Kalluri R., Zeisberg M., Fibroblasts in cancer. Nature Reviews Cancer 2006 6 5 392 401 2-s2.0-33646384428 10.1038/nrc1877
3. Orimo A., Gupta P. B., Sgroi D. C., Arenzana-Seisdedos F., Delaunay T., Naeem R., Carey V. J., Richardson A. L., Weinberg R. A., Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005 121 3 335 348 2-s2.0-18844428327 10.1016/j.cell.2005.02.034 (Pubitemid 40692295)
4. Kryczek I., Lange A., Mottram P., Alvarez X., Cheng P., Hogan M., Moons L., Wei S., Zou L., Machelon V., Emilie D., Terrassa M., Lackner A., Curiel T. J., Carmeliet P., Zou W., CXCL12 and vascular endothelial growth factor synergistically induce neonaniogenisis in human ovarian cancers. Cancer Research 2005 65 2 465 472 2-s2.0-19944431949
5. Gazitt Y., Akay C., Mobilization of myeloma cells involves SDF-1/CXCR4 signaling and downregulation of VLA-4. Stem Cells 2004 22 1 65 73 2-s2.0-0348141711 (Pubitemid 38018782)
6. Dwinell M. B., Ogawa H., Barrett K. E., Kagnoff M. F., SDF-1/CXCL12 regulates cAMP production and ion transport in intestinal epithelial cells via CXCR4. American Journal of Physiology: Gastrointestinal and Liver Physiology 2004 286 5 G844 G850 2-s2.0-1942519774 10.1152/ajpgi.00112.2003 (Pubitemid 38506817)
7. Yin A. H., Miraglia S., Zanjani E. D., Almeida-Porada G., Ogawa M., Leary A. G., Olweus J., Kearney J., Buck D. W., AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997 90 12 5002 5012 2-s2.0-0031453534 (Pubitemid 28007217)
8. Peichev M., Naiyer A. J., Pereira D., Zhu Z., Lane W. J., Williams M., Oz M. C., Hicklin D. J., Witte L., Moore M. A. S., Rafii S., Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood 2000 95 3 952 958 2-s2.0-12944253116 (Pubitemid 30062717)
9. Flamme I., Breier G., Risau W., Vascular endothelial growth factor (VEGF) and VEGF receptor 2 (flk-1) are expressed during vasculogenesis and vascular differentiation in the quail embryo. Developmental Biology 1995 169 2 699 712 2-s2.0-0029060389 10.1006/dbio.1995.1180
10. Ajili F., Kacem M., Tounsi H., Darouiche A., Enayfer E., Chebi M., Manai M., Boubaker S., Prognostic impact of angiogenesis in nonmuscle invasive bladder cancer as defined by microvessel density after immunohistochemical staining for CD34. Ultrastructural Pathology 2012 36 5 336 342 10.3109/01913123.2012.672847
11. Domanska U. M., Kruizinga R. C., Nagengast W. B., Timmer-Bosscha H., Huls G., de Vries E. G., Walenkamp A. M., A review on CXCR4/CXCL12 axis in oncology: no place to hide. European Journal of Cancer 2013 49 1 219 230 10.1016/j.ejca.2012.05.005
12. Chebib I., Shabani-Rad M. T., Chow M. S., Zhang J., Gao Z. H., Microvessel density and clinicopathologic characteristics in hepatocellular carcinoma with and without cirrhosis. Biomarker Insights 2007 2 59 68
13. Toi M., Inada K., Suzuki H., Tominaga T., Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Research and Treatment 1995 36 2 193 204 2-s2.0-0029143990 10.1007/BF00666040
14. Roskoski R. Jr., Vascular endothelial growth factor (VEGF) signaling in tumor progression. Critical Reviews in Oncology/Hematology 2007 62 3 179 213 2-s2.0-33947370773 10.1016/j.critrevonc.2007.01.006 (Pubitemid 46679285)
15. Tao Q., Chan A. T. C., Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments. Expert Reviews in Molecular Medicine 2007 9 12 1 24 2-s2.0-34548631786 10.1017/S1462399407000312 (Pubitemid 47398642)
16. Folkman J., Tumor angiogenesis: therapeutic implications. New England Journal of Medicine 1971 285 21 1182 1186 2-s2.0-0015231516
17. Cao Y., Zhang Z. L., Zhou M., Elson P., Rini B., Aydin H., Feenstra K., Tan M. H., Berghuis B., Tabbey R., Resau J. H., Zhou F. J., Teh B. T., Qian C. N., Pericyte coverage of differentiated vessels inside tumor vasculature is an independent unfavorable prognostic factor for patients with clear cell renal cell carcinoma. Cancer 2013 119 2 313 324 10.1002/cncr.27746
18. Fujita H., Ohuchida K., Mizumoto K., Nakata K., Yu J., Kayashima T., Cui L., Manabe T., Ohtsuka T., Tanaka M., α -Smooth muscle actin expressing stroma promotes an aggressive tumor biology in pancreatic ductal adenocarcinoma. Pancreas 2010 39 8 1254 1262 2-s2.0-78049317974 10.1097/MPA.0b013e3181dbf647
19. Olaso E., Santisteban A., Bidaurrazaga J., Gressner A. M., Rosenbaum J., Vidal-Vanaclocha F., Tumor-dependent activation of rodent hepatic stellate cells during experimental melanoma metastasis. Hepatology 1997 26 3 634 642 2-s2.0-0030823443 (Pubitemid 27392354)
20. Zhang Y., Tang H., Cai J., Zhang T., Guo J., Feng D., Wang Z., Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasion. Cancer Letters 2011 303 1 47 55 2-s2.0-79951852902 10.1016/j.canlet.2011.01.011
21. Wu X., Chen X., Zhou Q., Li P., Yu B., Li J., Qu Y., Yan J., Yu Y., Yan M., Zhu Z., Liu B., Su L., Hepatocyte growth factor activates tumor stromal fibroblasts to promote tumorigenesis in gastric cancer. Cancer Letters 2013 335 1 128 135 10.1016/j.canlet.2013.02.002
22. Popple A., Durrant L. G., Spendlove I., Rolland P., Scott I. V., Deen S., Ramage J. M., The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer. British Journal of Cancer 2012 106 7 1306 1313 2-s2.0-84859209464 10.1038/bjc.2012.49
23. Shiozaki T., Tabata T., Ma N., Yamawaki T., Motohashi T., Kondo E., Tanida K., Okugawa T., Ikeda T., Association of CXC chemokine receptor type 4 expression and clinicopathologic features in human vulvar cancer. International Journal of Gynecological Cancer 2013 23 6 1111 1117 10.1097/IGC.0b013e3182958f95
24. Lee B. C., Lee T. H., Avraham S., Avraham H. K., Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1 α in breast cancer cell migration through human brain microvascular endothelial cells. Molecular Cancer Research 2004 2 6 327 338 2-s2.0-3543065871 (Pubitemid 39025295)
25. Li J., Zhang X. S., Xie D., Deng H. X., Gao Y. F., Chen Q. Y., Huang W. L., Masucci M. G., Zeng Y. X., Expression of immune-related molecules in primary EBV positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression. Cancer Biology and Therapy 2007 6 12 1997 2004 2-s2.0-42549160064 (Pubitemid 351590415)
26. Wang N., Wu Q. L., Fang Y., Mai H. Q., Zeng S., Shen G. P., Hou J. H., Zeng Y. X., Expression of chemokine receptor CXCR4 in nasopharyngeal carcinoma: pattern of expression and correlation with clinical outcome. Journal of Translational Medicine 2005 3 article 26 2-s2.0-27344436242 10.1186/1479-5876-3- 26 (Pubitemid 41522081)
27. Saigusa S., Toiyama Y., Tanaka K., Yokoe T., Okugawa Y., Fujikawa H., Matsusita K., Kawamura M., Inoue Y., Miki C., Kusunoki M., Cancer-associated fibroblasts correlate with poor prognosis in rectal cancer after chemoradiotherapy. International Journal of Oncology 2011 38 3 655 663 2-s2.0-79952035675 10.3892/ijo.2011.906
28. Orimo A., Weinberg R. A., Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle 2006 5 15 1597 1601 2-s2.0-33747859659 (Pubitemid 44285243)
29. Brown L. F., Guidi A. J., Schnitt S. J., van de Water L., Iruela-Arispe M. L., Yeo T. K., Tognazzi K., Dvorak H. F., Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clinical Cancer Research 1999 5 5 1041 1056 2-s2.0-0032933778 (Pubitemid 29233218)
30. Fukumura D., Xavier R., Sugiura T., Chen Y., Park E. C., Lu N., Selig M., Nielsen G., Taksir T., Jain R. K., Seed B., Tumor induction of VEGF promoter activity in stromal cells. Cell 1998 94 6 715 725 2-s2.0-0032544686 10.1016/S0092-8674(00)81731-6 (Pubitemid 28436004)
31. Bachelder R. E., Crago A., Chung J., Wendt M. A., Shaw L. M., Robinson G., Mercurio A. M., Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Research 2001 61 15 5736 5740 2-s2.0-0035422178 (Pubitemid 32769088)
32. Liang J. F., Wang H. K., Xiao H., Li N., Cheng C. X., Zhao Y. Z., Ma Y. B., Gao J. Z., Bai R. B., Zheng H. X., Relationship and prognostic significance of SPARC and VEGF protein expression in colon cancer. Journal of Experimental and Clinical Cancer Research 2010 29 1, article 71 2-s2.0-77953511554 10.1186/1756-9966-29-71
33. van Trappen P. O., Steele D., Lowe D. G., Baithun S., Beasley N., Thiele W., Weich H., Krishnan J., Shepherd J. H., Pepper M. S., Jackson D. G., Sleeman J. P., Jacobs I. J., Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesis. Journal of Pathology 2003 201 4 544 554 2-s2.0-10744226603 10.1002/path.1467 (Pubitemid 38256403)
34. Lyden D., Hattori K., Dias S., Costa C., Blaikie P., Butros L., Chadburn A., Heissig B., Marks W., Witte L., Wu Y., Hicklin D., Zhu Z., Hackett N. R., Crystal R. G., Moore M. A. S., Hajjar K. A., Manova K., Benezra R., Rafii S., Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nature Medicine 2001 7 11 1194 1201 2-s2.0-0035160312 10.1038/nm1101-1194 (Pubitemid 33063774)
35. Carmeliet P., Jain R. K., Angiogenesis in cancer and other diseases. Nature 2000 407 6801 249 257 2-s2.0-0034648765 10.1038/35025220
36. Heissig B., Hattori K., Dias S., Friedrich M., Ferris B., Hackett N. R., Crystal R. G., Besmer P., Lyden D., Moore M. A. S., Werb Z., Rafii S., Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of Kit-ligand. Cell 2002 109 5 625 637 2-s2.0-18444389451 10.1016/S0092-8674(02)00754-7 (Pubitemid 34628725)
37. Hwang H. S., Maeng Y. S., Kim Y. H., Kwon Y. G., Park Y. W., Kim I. K., Nestin expression during differentiation of fetal endothelial progenitor cells and hypoxic culture of human umbilical vein endothelial cells. Acta Obstetricia et Gynecologica Scandinavica 2008 87 6 643 651 2-s2.0-45849089967 10.1080/00016340802085326 (Pubitemid 351882485)
38. Patenaude A., Parker J., Karsan A., Involvement of endothelial progenitor cells in tumor vascularization. Microvascular Research 2010 79 3 217 223 2-s2.0-77952099582 10.1016/j.mvr.2010.01.007
39. Chen T. W., Yang Z. G., Wang Q. L., Li Y., Qian L. L., Chen H. J., Whole tumour quantitative measurement of first-pass perfusion of oesophageal squamous cell carcinoma using 64-row multidetector computed tomography: correlation with microvessel density. European Journal of Radiology 2011 79 2 218 223 2-s2.0-80052183720 10.1016/j.ejrad.2010.03.024
40. Qian C. N., Huang D., Wondergem B., Teh B. T., Complexity of tumor vasculature in clear cell renal cell carcinoma. Cancer 2009 115 10 2282 2289 2-s2.0-65949096075 10.1002/cncr.24238
41. Elpek G. Ö., Gelen T., Aksoy N. H., Erdoan A., Dertsiz L., Demircan A., Keleş N., The prognostic relevance of angiogenesis and mast cells in squamous cell carcinoma of the oesophagus. Journal of Clinical Pathology 2001 54 12 940 944 2-s2.0-0035675877 (Pubitemid 34032889)
42. Gadducci A., Viacava P., Cosio S., Fanelli G., Fanucchi A., Cecchetti D., Cristofani R., Genazzani A. R., Intratumoral microvessel density, response to chemotherapy and clinical outcome of patients with advanced ovarian carcinoma. Anticancer Research B 2003 23 1 549 556 2-s2.0-0037233629 (Pubitemid 36358449)
43. Foote R. L., Weidner N., Harris J., Hammond E., Lewis J. E., Vuong T., Ang K. K., Fu K. K., Evaluation of tumor angiogenesis measured with microvessel density (MVD) as a prognostic indicator in nasopharyngeal carcinoma: results of RTOG 9505. International Journal of Radiation Oncology Biology Physics 2005 61 3 745 753 2-s2.0-13844254877 10.1016/j.ijrobp.2004.07.694 (Pubitemid 40247969)
44. Kountakis S. E., Encyclopedia of Otolaryngology, Head and Neck Surgery 2013 Springer
45. Shaked Y., Kerbel R. S., Antiangiogenic strategies on defense: on the possibility of blocking rebounds by the tumor vasculature after chemotherapy. Cancer Research 2007 67 15 7055 7058 2-s2.0-34547617338 10.1158/0008-5472.CAN- 07-0905 (Pubitemid 47206528)